Germany's Fresenius weighing bid for generic drugmaker Akorn: Bbg

(Reuters) - German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc , Bloomberg reported on Friday, citing people familiar with the matter.

Germany's Fresenius weighing bid for generic drugmaker Akorn: Bbg
Read More


Bagikan Berita Ini